Literature DB >> 1744314

Vasopressin in septic shock--a useful or dangerous agent?

H M Morrison, P Doepfner, G R Park.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744314     DOI: 10.1007/bf01709888

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport.

Authors:  J F Hesselvik; B Brodin
Journal:  Crit Care Med       Date:  1989-02       Impact factor: 7.598

2.  The physiological effects of vasopressin when used to control intra-abdominal bleeding.

Authors:  M P Shelly; R Greatorex; R Y Calne; G R Park
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  Reversal of intractable septic shock with norepinephrine therapy.

Authors:  D Meadows; J D Edwards; R G Wilkins; P Nightingale
Journal:  Crit Care Med       Date:  1988-07       Impact factor: 7.598

4.  Norepinephrine therapy has no deleterious renal effects in human septic shock.

Authors:  P Desjars; M Pinaud; D Bugnon; F Tasseau
Journal:  Crit Care Med       Date:  1989-05       Impact factor: 7.598

  4 in total
  3 in total

Review 1.  Sepsis and septic shock. II. Treatment.

Authors:  J Mayer; R Hajek; J Vorlicek; M Tomiska
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

Review 2.  [Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function].

Authors:  C Ertmer; A W Sielenkämper; H van Aken; H-G Bone; M Westphal
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

Review 3.  Management of vasodilatory shock: defining the role of arginine vasopressin.

Authors:  Martin W Dunser; Volker Wenzel; Andreas J Mayr; Walter R Hasibeder
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.